U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C17H23N7O5
Molecular Weight 405.4084
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TALTIRELIN

SMILES

CN1C(=O)C[C@H](NC1=O)C(=O)N[C@@H](CC2=CN=CN2)C(=O)N3CCC[C@H]3C(N)=O

InChI

InChIKey=LQZAIAZUDWIVPM-SRVKXCTJSA-N
InChI=1S/C17H23N7O5/c1-23-13(25)6-10(22-17(23)29)15(27)21-11(5-9-7-19-8-20-9)16(28)24-4-2-3-12(24)14(18)26/h7-8,10-12H,2-6H2,1H3,(H2,18,26)(H,19,20)(H,21,27)(H,22,29)/t10-,11-,12-/m0/s1

HIDE SMILES / InChI

Molecular Formula C17H23N7O5
Molecular Weight 405.4084
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Description
Curator's Comment: description was created based on several sources, including https://www.drugs.com/international/taltirelin.html | https://www.ncbi.nlm.nih.gov/pubmed/23087672 | https://www.ncbi.nlm.nih.gov/pubmed/25142535

Taltirelin (TA-0910), a synthetic thyrotropin-releasing hormone (TRH) analog, has been developed by Tanabe Seiyaku for the treatment of neurodegenerative diseases. Taltirelin mimics the physiological actions of TRH, but with a much longer half-life and duration of effects, and little development of tolerance following prolonged dosing. Taltirelin has nootropic, neuroprotective and analgesic effects. Taltirelin is primarily being researched for the treatment of spinocerebellar ataxia; limited research has also been carried out with regard to other neurodegenerative disorders, e.g., spinal muscular atrophy.

Approval Year

Targets

Targets

Primary TargetPharmacologyConditionPotency
36.0 nM [EC50]
Conditions

Conditions

ConditionModalityTargetsHighest PhaseProduct
Primary
Ceredist

Approved Use

Unknown
PubMed

PubMed

TitleDatePubMed
Blood-brain permeability of [3H]-(3-methyl-His2)thyrotropin-releasing hormone (MeTRH) in mice: effects of TRH and its analogues.
2003
Excitation of locus coeruleus noradrenergic neurons by thyrotropin-releasing hormone.
2009 Dec 1
Taltirelin is a superagonist at the human thyrotropin-releasing hormone receptor.
2012
Thyrotropin-releasing hormone receptor type 1 (TRH-R1), not TRH-R2, primarily mediates taltirelin actions in the CNS of mice.
2013 May
Patents

Sample Use Guides

Patients took taltirelin (5 mg bid) or placebo for 28 to 52 weeks.
Route of Administration: Oral
HEK-EM 293 (human embryonic kidney) cells stably expressing TRH-R were seeded in black-walled, clear bottomed 96-well plates (Corning, NY, USA) at a density of 60,000 cells/well in DMEM with 10% fetal bovine serum and incubatedfor24hat37◦C in5%CO2. The following day, the culture media was replaced with 100 μl of Hank’s balanced salt solution with 20 mM HEPES, pH 7.5 and the cells were loaded with100 μl of calcium 4 fluorescent dye (Molecular Devices, Sunnyvale, CA, USA) for 1 h at room temperature before addition of compounds .Transient changes in intracellular [Ca++] induced by TALTIRELIN were measured using the FLIPRTETRA system (Molecular Devices, Sunnyvale, CA, USA). Changes in fluorescence were detected at the emission wavelength ranges from 515 to 575 nm. The agonistic responses of ligands were assessed immediately upon their addition in a concentration range from 0.1 nMto30 μM.
Substance Class Chemical
Created
by admin
on Sat Dec 16 16:20:16 GMT 2023
Edited
by admin
on Sat Dec 16 16:20:16 GMT 2023
Record UNII
DOZ62MV6A5
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
TALTIRELIN
INN   MART.   MI   WHO-DD  
INN  
Official Name English
TALTIRELIN [MART.]
Common Name English
TALTIRELIN [MI]
Common Name English
TA-0910
Code English
taltirelin [INN]
Common Name English
Taltirelin [WHO-DD]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C76367
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
Code System Code Type Description
WIKIPEDIA
TALTIRELIN
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
MERCK INDEX
m10447
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY Merck Index
DRUG CENTRAL
2560
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
INN
7503
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
CAS
103300-74-9
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
FDA UNII
DOZ62MV6A5
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
NCI_THESAURUS
C77011
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
PUBCHEM
114750
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
SMS_ID
100000083229
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
EVMPD
SUB10816MIG
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
CHEBI
135653
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
ChEMBL
CHEMBL2107016
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
EPA CompTox
DTXSID0043763
Created by admin on Sat Dec 16 16:20:17 GMT 2023 , Edited by admin on Sat Dec 16 16:20:17 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
SALT/SOLVATE -> PARENT
SOLVATE->ANHYDROUS
PARENT -> DERIVATIVE
Related Record Type Details
ACTIVE MOIETY